Taper dosage or discontinue if possible at 3 month intervals. Evaluate for presence of HLA-B*1502 allele (esp. in Asians), if present carbamazepine should not be used; increased risk of severe ...
Taper dosage or discontinue if possible at 3 month intervals. Evaluate for presence of HLA-B*1502 allele (esp. in Asians), if present carbamazepine should not be used; increased risk of severe ...